1-3 of 3
Rosaura Casas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial

Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martínez-Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente León, Ana Gómez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius, Rosaura Casas
Journal: Diabetes Care
Diabetes Care 2021;44(7):1604–1612
https://doi.org/10.2337/dc21-0318
Published: 21 May 2021
View articletitled, Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Open the PDF for Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial in another window
Journal Articles

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial

Stina Axelsson, PHD, Mikael Chéramy, PHD, Linda Åkerman, MSC, Mikael Pihl, MSC, Johnny Ludvigsson, MD, PHD, Rosaura Casas, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3418–3424
https://doi.org/10.2337/dc12-2251
Published: 15 October 2013
View articletitled, Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
Open the PDF for Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial in another window
Includes: Supplementary data
Journal Articles

Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes

Rachel E.J. Besser, PHD, Beverley M. Shields, PHD, Rosaura Casas, PHD, Andrew T. Hattersley, DM, Johnny Ludvigsson, MD
Journal: Diabetes Care
Diabetes Care 2013;36(2):195–201
https://doi.org/10.2337/dc12-0836
Published: 17 January 2013
View articletitled, Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes
Open the PDF for Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes in another window
Includes: Supplementary data